The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients-Reference-Cited by-同舟云学术

The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients

Published:2020-11-01 Issue:11 Volume:16 Page:1065-1074
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Benvenuti Francesco¹,Zanatta Elisabetta¹,Avouac Jérôme²,Müller-Ladner Ulf³,Cozzi Franco⁴,Hoffmann-Vold Anna-Maria⁵,Gabrielli Armando⁶,Distler Oliver⁷,Matucci-Cerinic Marco⁸,Allanore Yannick²,Doria Andrea¹

Affiliation:

1. Division of Rheumatology, Department of Medicine-DIMED, Padova University Hospital, Padova, Italy

2. Rhumatologie, Hôpital Cochin, APHP, Université de Paris, Paris, France

3. Department of Internal Medicine and Rheumatology, Justus‐Liebig University Giessen, Bad Nauheim, Germany

4. Internal Medicine Unit, Ospedale Classificato Villa Salus, Venice, Italy

5. Department of Rheumatology, Oslo University Hospital, Oslo, Norway

6. Ancona, Università Politecnica Delle Marche, Italy

7. Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

8. Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2021.1836962

Reference77 articles.

1. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database

2. Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients

3. TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients

4. Scleroderma: from cell and molecular mechanisms to disease models

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort;RMD Open;2024-05

2. Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?;Autoimmunity Reviews;2023-09

3. Clinical Trial Enrichment in Systemic Sclerosis-Associated Interstitial Lung Disease;Chest;2023-03

4. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research;Chest;2023-03

5. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort;Rheumatology;2022-03-28